Related references
Note: Only part of the references are listed.Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
Cecilia Villegas et al.
IUBMB LIFE (2022)
The relevance of quantitative ethnobotanical indices for ethnopharmacology and ethnobotany
Marco Leonti
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Role of Cholinergic Signaling in Alzheimer's Disease
Zhi-Ru Chen et al.
MOLECULES (2022)
Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration
Aymeric Silvin et al.
IMMUNITY (2022)
From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples
Stergios Pirintsos et al.
MOLECULES (2022)
Plant-derived natural products for drug discovery: current approaches and prospects
Noohi Nasim et al.
NUCLEUS-INDIA (2022)
The new therapy for Alzheimer's disease: from a hope for a few to a false hope?
Stefania Orini et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)
gamma-Secretase in Alzheimer's disease
Ji-Yeun Hur
EXPERIMENTAL AND MOLECULAR MEDICINE (2022)
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review
Danko Jeremic et al.
AGEING RESEARCH REVIEWS (2021)
Roles of microglia in Alzheimer's disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention
Kazuyuki Takata et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase In-hibitors
Maja Przybylowska et al.
CURRENT NEUROPHARMACOLOGY (2021)
The Fragility of Temporal Memory in Alzheimer's Disease
Jin-Hyuck Park et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Iron Homeostasis Disorder and Alzheimer's Disease
Yu Peng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Acute and Chronic Cognitive Effects of a Sage Extract: A Randomized, Placebo Controlled Study in Healthy Humans
Emma L. Wightman et al.
NUTRIENTS (2021)
Spatial memory deficiency early in 6xTg Alzheimer's disease mouse model
Shinwoo Kang et al.
SCIENTIFIC REPORTS (2021)
ENGAGE and EMERGE: Truth and consequences?
Lewis H. Kuller et al.
ALZHEIMERS & DEMENTIA (2021)
Emerging roles of oxidative stress in brain aging and Alzheimer's disease
Andra Ionescu-Tucker et al.
NEUROBIOLOGY OF AGING (2021)
Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro
Meghan K. Cash et al.
NEUROBIOLOGY OF AGING (2021)
Neuroprotective Herbs for the Management of Alzheimer's Disease
Julie Gregory et al.
BIOMOLECULES (2021)
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2021)
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Nour M. Moussa-Pacha et al.
MEDICINAL RESEARCH REVIEWS (2020)
Rational polytherapy in the treatment of cholinergic seizures
Jerome Niquet et al.
NEUROBIOLOGY OF DISEASE (2020)
Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool
Zhe Ying Ha et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2020)
Inhibitors of Cholinesterases in Pharmacology: the Current Trends
Miroslav Pohanka
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)
Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer's Disease
Hareram Birla et al.
CURRENT NEUROPHARMACOLOGY (2020)
Quality assessment of herbal medicines based on chemical fingerprints combined with chemometrics approach: A review
Yun Li et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease
Arsalan Hashemiaghdam et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
N-Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present)
Hazem Ahmed et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
A Randomized, Crossover Study of the Acute Cognitive and Cerebral Blood Flow Effects of Phenolic, Nitrate and Botanical Beverages in Young, Healthy Humans
Philippa A. Jackson et al.
NUTRIENTS (2020)
Chronic Supplementation with a Mix ofSalvia officinalisandSalvia lavandulaefoliaImproves Morris Water Maze Learning in Normal Adult C57Bl/6J Mice
Anne-Laure Dinel et al.
NUTRIENTS (2020)
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval
Martin Tolar et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Meysam Amidfar et al.
LIFE SCIENCES (2020)
Comprehensive Review on Alzheimer's Disease: Causes and Treatment
Zeinab Breijyeh et al.
MOLECULES (2020)
Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease
Vandana Bhatia et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer's disease
Seung-Min Yoo et al.
BMB REPORTS (2020)
Traditional oriental medicine for sensorineural hearing loss: Can ethnopharmacology contribute to potential drug discovery?
Rodrigo Castaneda et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Current and Future Treatments in Alzheimer's Disease
Alireza Atri
SEMINARS IN NEUROLOGY (2019)
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders
Sandeep Kumar Singh et al.
NEUROTHERAPEUTICS (2019)
Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation
Tee Jong Huat et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Salvia officinalis essential oil: Chemical analysis and evaluation of anti-enzymatic and antioxidant bioactivities
S. Kammoun El Euch et al.
SOUTH AFRICAN JOURNAL OF BOTANY (2019)
Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence
Antoine Karam et al.
COMMUNITY MENTAL HEALTH JOURNAL (2019)
Quality Standards for Herbal Drugs and Herbal Drug Preparations - Appropriate or Improvements Necessary?
Reinhard Laenger et al.
PLANTA MEDICA (2018)
Mitochondria and Mitochondrial Cascades in Alzheimer's Disease
Russell H. Swerdlow
JOURNAL OF ALZHEIMERS DISEASE (2018)
A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age
N. S. L. Perry et al.
PHYTOMEDICINE (2018)
Inflammation: the link between comorbidities, genetics, and Alzheimer's disease
Estella A. Newcombe et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Acute ingestion of rosemary water: Evidence of cognitive and cerebrovascular effects in healthy adults
Mark Moss et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects
Adrian L. Lopresti
DRUGS IN R&D (2017)
Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease
Charbel E-H. Moussa
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Reverse ethnopharmacology and drug discovery
Marco Leonti et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications
Jinfan Tian et al.
CURRENT VASCULAR PHARMACOLOGY (2017)
Differential changes in hippocampal CaMKII and GluA1 activity after memory training involving different levels of adaptive forgetting
Nicolas Fraize et al.
LEARNING & MEMORY (2017)
Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Guoyan Yang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease
Katsuyoshi Mizukami et al.
NEUROPATHOLOGY (2016)
The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial
Jinzhou Tian et al.
TRIALS (2016)
Nutrition and Dementia: Evidence for Preventive Approaches?
Marco Canevelli et al.
NUTRIENTS (2016)
Alzheimer's Association Report 2015 Alzheimer's disease facts and figures
ALZHEIMERS & DEMENTIA (2015)
Cholinesterase inhibitors: an example of geographic variation in prescribing patterns within a drug class
Raymond K. Fong et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Systematic Review of Clinical Trials Assessing Pharmacological Properties of Salvia Species on Memory, Cognitive Impairment and Alzheimer's Disease
Marco Miroddi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
Oxidative stress in Alzheimer's disease
Zhichun Chen et al.
NEUROSCIENCE BULLETIN (2014)
Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation
Kazunori Sasaki et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
γ-Secretase inhibitors and modulators
Todd E. Golde et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
David Olivares et al.
Current Alzheimer Research (2013)
Huperzine A for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Guoyan Yang et al.
PLOS ONE (2013)
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects
Katherine A. MacLean et al.
PSYCHOPHARMACOLOGY (2013)
Neuropsychology of Alzheimer's Disease
Jordi Pena-Casanova et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans
Mohini Ranganathan et al.
BIOLOGICAL PSYCHIATRY (2012)
Antiangiogenic Effect of Carnosic Acid and Carnosol, Neuroprotective Compounds in Rosemary Leaves
Tomoko Kayashima et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2012)
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
H. A. Tejeda et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Quality of herbal medicines: Challenges and solutions
Junhua Zhang et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2012)
Short-Term Study on the Effects of Rosemary on Cognitive Function in an Elderly Population
Andrew Pengelly et al.
JOURNAL OF MEDICINAL FOOD (2012)
Butyrylcholinesterase Is Associated With β-Amyloid Plaques in the Transgenic APPSWE/PSEN1dE9 Mouse Model of Alzheimer Disease
Sultan Darvesh et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial
Bruno Vellas et al.
LANCET NEUROLOGY (2012)
Acute and post-acute behavioral and psychological effects of salvinorin A in humans
Peter H. Addy
PSYCHOPHARMACOLOGY (2012)
Use of Salvia divinorum in a Nationally Representative Sample
Brian E. Perron et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2012)
Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma
Mark Moss et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2012)
Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging?
Elaine Perry et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
γ-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes
Bruno P. Imbimbo et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum
Matthew W. Johnson et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Salvia divinorum use and phenomenology: results from an online survey
H. R. Sumnall et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults
David O. Kennedy et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A
Christopher W. Cunningham et al.
PHARMACOLOGICAL REVIEWS (2011)
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial
John E. Mendelson et al.
PSYCHOPHARMACOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
Legally Tripping: A Qualitative Profile of Salvia Divinorum Use Among Young Adults
Brian C. Kelly
JOURNAL OF PSYCHOACTIVE DRUGS (2011)
Use patterns and self-reported effects of Salvia divinorum An Internet-based survey
Matthew J. Baggott et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Differential effects of the aromas of Salvia species on memory and mood
Lucy Moss et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Kappa opioids and the modulation of pain
Bronwyn Kivell et al.
PSYCHOPHARMACOLOGY (2010)
Phenolic Compounds Prevent Alzheimer's Pathology through Different Effects on the Amyloid-β Aggregation Pathway
Tsuyoshi Hamaguchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
ALZHEIMER'S DISEASE AND IMPLICIT MEMORY
Sergio Machado et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2009)
Subjective Effects of Salvia Divinorum: LSD- or Marijuana-like?
Dawn N. Albertson et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2009)
Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease
H. Q. Lin et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Inhibitory effect of Turkish Rosmarinus officinalis L. on acetylcholinesterase and butyrylcholinesterase enzymes
Ilkay Orhan et al.
FOOD CHEMISTRY (2008)
South African Salvia species: A review of biological activities and phytochemistry
G. P. P. Kamatou et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers
Andrew B. Scholey et al.
PSYCHOPHARMACOLOGY (2008)
Use of herbs among adults based on evidence-based indications: Findings from the National Health Interview Survey
Aditya Bardia et al.
MAYO CLINIC PROCEEDINGS (2007)
Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery
DO Kennedy et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Towards a unifying hypothesis of Alzheimer's disease: Cholinergic system linked to plaques, tangles and neuroinflammation
Kannan Sivaprakasam
CURRENT MEDICINAL CHEMISTRY (2006)
The pharmacological effects of Salvia species on the central nervous system
Mohsen Imanshahidi et al.
PHYTOTHERAPY RESEARCH (2006)
Rapid absorption of dietary 1,8-cineole results in critical blood concentration of cineole and immediate cessation of eating in the common brushtail possum (Trichosurus vulpecula)
RR Boyle et al.
JOURNAL OF CHEMICAL ECOLOGY (2005)
Ethnopharmacology and drug discovery
B Patwardhan
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Neuronal Ca2+/calmodulin-dependent protein kinase II -: Discovery, progress in a quarter of a century, and perspective:: Implication for learning and memory
T Yamauchi
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers
NTJ Tildesley et al.
PHYSIOLOGY & BEHAVIOR (2005)
Acetylcholinesterase and its inhibition in Alzheimer disease
RM Lane et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza
YH Ren et al.
PLANTA MEDICA (2004)
Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties
DO Kennedy et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers
NTJ Tildesley et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Salvia for dementia therapy:: review of pharmacological activity and pilot tolerability clinical trial
NSL Perry et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease:: a double blind, randomized and placebo-controlled trial
S Akhondzadeh et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2003)
Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm)
DO Kennedy et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo
NSL Perry et al.
PHYTOMEDICINE (2002)
In-vitro activity of S-lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease
NSL Perry et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease
DL Bai et al.
CURRENT MEDICINAL CHEMISTRY (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory
G Wake et al.
JOURNAL OF ETHNOPHARMACOLOGY (2000)
Share Paper
